A group of HIV-positive men met at at the border between the United States and Mexico Sunday to kiss, creating a powerful display of defiance in the face of discrimination. Ahead of World AIDs Day, MPact Global Action for Gay Men's Health and Rights hosted the third annual Besoton Sidoso Internacional, also known as the International HIV Kiss-In, in Friendship Park/Parque de la Amistad on the border between California and Mexico.
Since its introduction in the late 1980s, HIV antiretroviral therapy (ART) has saved millions of lives by transforming HIV from a fatal disease into a chronic, manageable condition. Despite these achievements, ART is not a cure, and even after decades of treatment, HIV will rebound rapidly in nearly all individuals who stop therapy. Lifelong ART is accompanied by numerous challenges, such as social stigma and fatigue associated with the need to take pills daily.
Mountain View Police Department Detective Lauren Riffel was the lead investigator into accusations that Sarceño Orla drugged and sexually assaulted at least 19 men while working as a barber. "When you have more than one, that's crazy enough," Det. Riffel said. "When you have more than 5, 10, going all the way up to over 60 people - talking to 60 humans that were victimized in a certain population, it's terrible to have to hear these stories over and over again."
Drug users have found a dangerous and cheap way to get a high that is fueling a surge in HIV diagnoses. Called 'bluetoothing', the practice involves injecting yourself with the blood of another drug user in an effort to share in their high. Already common in Fiji, the practice has driven an 11-fold surge in HIV cases on the Pacific island nation in just a decade.
After he became a hot young movie star, he began relying on the services of escorts, provided to him by his friend, Hollywood madam Heidi Fleiss. There also were nights at the Playboy mansion and flings with men while high. During his very public flameout in 2011, he boasted about his tiger blood and two live-in girlfriends, who in turn told the New York Post about their big shared bed and triple-decker sex life.
Tens of thousands of HIV patients could soon to be offered a monthly pill to control the virus and keep the virus at bay. Results from a landmark trial show the drug was as effective as the daily cocktail of pills patients currently take. Experts claim the new pill, known as a nucleoside reverse transcriptase translocation inhibitor (NRTTI), could fulfill an 'unmet need' and replace the daily pills, improving compliance.
In December 2023, his conviction for causing serious harm to two partners by intentionally or recklessly infecting them with HIV was quashed by the Supreme Court.
"I didn't physically take care of him, and I wasn't a nurse or anything like that, but I definitely helped, certainly after the accident. I helped organize and sort of focus Chris on a different set of priorities than he probably had before his accident."
"It's a milestone moment in the history of HIV," says Daniel O'Day, chairman and CEO of Gilead Sciences. "In our opinion, it's the best tool yet in helping end the HIV epidemic for everyone, everywhere."